Stem Cell Transplant Helps Retired New Jersey Principal PDF Print E-mail
Saturday, 05 September 2009 09:24
taken from http://science.howstuffworks.com/cellular-microscopic-biology/stem-cell5.htmCovered within a recent MyCentralJersey article, New Jersey resident, Michael George feels “reborn” after having his own adult stem cells implanted in him to treat his Scleroderma in a new stem cell treatment. The retired William C. McGinnis School principal, who in April was taken off all medications, including antibiotics, related to his transplant said that “I feel really good,” and “It's great to be alive.” It was at his one-year check-up in April doctors told George, an avid fisherman, that he can now do anything he wants.

Just before the March 13, 2008, adult stem-cell transplant, George's skin was stiff and his face was tight. He had a hard time swallowing. Doctors were concerned his condition was spreading internally to the point it might close his esophagus and damage his heart and lungs. The procedure George underwent at Northwestern Memorial Hospital in Chicago involved taking stem cells from his bone marrow, cleaning and freezing them while he received large doses of chemotherapy to cleanse his immune system before the stem cells were put back into his body to grow.

George stayed in the hospital for nearly three weeks and remained in Chicago for about three months staying in a hotel affiliated with the hospital which offered apartment-like accommodations for transplant patients. The night he returned to Perth Amboy, New Jersey, George remembers being able to bend down to pick up the luggage from the trunk of the cab. These days his knees are giving him some trouble when he bends due to arthritis.

George said the procedure didn't cure him, but it stopped the disease and reverses it to a certain extent.

“In April the doctor said "are you sure I didn't give you a lung transplant, instead of a stem cell transplant,” he said, noting both his lungs and heart are now in good condition. Following the transplant, George said his body has a low tolerance for cold weather and he has to really bundle up. He may spend part of the upcoming winter visiting a friend in California and his son, who lives on the island of St. Vincent.

However, Stem Cell Treatment isn't cheap. A lot of overseas stem cell companies take a lot of flack for charging patients usually in the range of $20,000-30,000 dollar for the adult stem cell therapy that can improve patients’ lives. However, stem cell treatment in the US isn’t cheap either at over $200,000 for an “experimental” treatment. Similarly, Stem Cell research has been mired in controversy, having become one of the biggest issues dividing the scientific and religious communities around the world.

George said he really appreciates life and everyone at his church, the school district and city who wrote or e-mailed him and contributed toward his medical expenses, which were more than $200,000. I don’t want money to be the main issue, as the important thing is Michael did improve his quality of life and you can’t put a price tag on that. However, those overseas stem cell therapy companies don’t look so bad after all when you compare them to the $200,000 + for adult stem cells in the United States for similar “unproven” treatments.

Read the full article here.
 
More articles :

» Causes Found for Stiff Skin Conditions

By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about , a condition affecting about one in 5,000 people that leads to hardening of the...

» Multidisciplinary Therapy May Improve Systemic Sclerosis

For patients with (SSc), a multidisciplinary program offers better improvement of grip strength, maximal mouth opening (MMO), six-minute walk distance (6MWD), and SSc Health Assessment Questionnaire (HAQ) score than regular outpatient care,...

» Therapies for Scleroderma-related Pulmonary Arterial Hypertension

Paul M. HassounPosted: 08/20/2009; Expert Rev Resp Med. 2009;3(2):187-196. © 2009 Expert Reviews Ltd.Pulmonary arterial hypertension (PAH), a common complication of systemic sclerosis, carries a very severe prognosis and is one of the leading...

» A Simple Blood Test Could Hold The Clue...

In a recent press release, the reported that a simple blood test could hold the clue and may even save lives. is a common condition, especially in teenagers, affecting approximately 10 million people in the UK. It can vary from being mild to very...

» Immune Therapy Developed for Atherosclerosis

is when plaque builds up in the arteries; and it can cause serious problems in the heart. However new strategies are helping patients combat atherosclerosis; and could change the treatment landscape of heart disease, all together.It was in the...

» Actelion Pharmaceuticals Announces Commercial Availability Of Epoprostenol For Injection For The Treatment Of Pulmonary Arterial Hypertension

Actelion Pharmaceuticals US, Inc. today  announced the commercial availability of Epoprostenol for Injection, an improved formulation of epoprostenol that is stable at room temperature, for the treatment of primary pulmonary hypertension and...

Add comment

Do feel free to leave your comments, as they would add value and knowledge to the community. However, please refrain from making any disparaging, uninformed, or unrelated comments. Thanks :)

Security code
Refresh